PetIQ, Inc. (PETQ)
NASDAQ: PETQ · IEX Real-Time Price · USD
22.05
+0.47 (2.18%)
At close: Jun 17, 2024, 4:00 PM
21.81
-0.24 (-1.08%)
After-hours: Jun 17, 2024, 4:20 PM EDT

Company Description

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally.

It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.

It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars.

In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands.

It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names.

In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services.

It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.

PetIQ, Inc.
PetIQ logo
Country United States
Founded 2010
IPO Date Jul 21, 2017
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,121
CEO McCord Christensen

Contact Details

Address:
Petiq Llc, 230 E. Riverside Dr.
Eagle, Idaho 83616
United States
Phone 208-939-8900
Website petiq.com

Stock Details

Ticker Symbol PETQ
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001668673
CUSIP Number 71639T106
ISIN Number US71639T1060
SIC Code 5122

Key Executives

Name Position
McCord Christensen Chairman of the Board and Chief Executive Officer
Michael A. Smith President and Chief Operating Officer
Zvi Glasman Chief Financial Officer
William J. Carter Executive Vice President and General Counsel
John Pearson Executive Vice President of Services and Manufactured Products

Latest SEC Filings

Date Type Title
Jun 12, 2024 8-K Current Report
May 9, 2024 10-Q Quarterly Report
May 8, 2024 8-K Current Report
Apr 19, 2024 ARS Filing
Apr 19, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 19, 2024 DEF 14A Other definitive proxy statements
Apr 5, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 29, 2024 10-K Annual Report
Feb 28, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals